chr9-37521695-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012166.3(FBXO10):āc.2074C>Gā(p.Gln692Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012166.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO10 | NM_012166.3 | c.2074C>G | p.Gln692Glu | missense_variant | 8/11 | ENST00000432825.7 | NP_036298.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO10 | ENST00000432825.7 | c.2074C>G | p.Gln692Glu | missense_variant | 8/11 | 1 | NM_012166.3 | ENSP00000403802 | P1 | |
FBXO10 | ENST00000276960.7 | c.*281C>G | 3_prime_UTR_variant, NMD_transcript_variant | 7/9 | 5 | ENSP00000276960 | ||||
FBXO10 | ENST00000543968.5 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461700Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727134
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.2074C>G (p.Q692E) alteration is located in exon 8 (coding exon 7) of the FBXO10 gene. This alteration results from a C to G substitution at nucleotide position 2074, causing the glutamine (Q) at amino acid position 692 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.